Mesenchymal stromal cells for the treatment of critical limb ischemia: context and perspective

Cell therapy using mesenchymal stromal cells (MSCs) is a promising new avenue of treatment for critical limb ischemia (CLI). Preclinical studies have suggested that MSCs enhance neovascularization in ischemic limbs. In this commentary, we discuss a recent study by Gupta and colleagues, one of the fi...

Descripción completa

Detalles Bibliográficos
Autores principales: Gremmels, Hendrik, Fledderus, Joost O, Teraa, Martin, Verhaar, Marianne C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4055075/
https://www.ncbi.nlm.nih.gov/pubmed/24246031
http://dx.doi.org/10.1186/scrt351

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4055075/
https://www.ncbi.nlm.nih.gov/pubmed/24246031
http://dx.doi.org/10.1186/scrt351

Ejemplares similares